<i>HCK</i> can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
Xudong Zhu, Yixiao Zhang, Yang Bai, Xi Gu, Guanglei Chen, Lisha Sun, Yulun Wang, Xinbo Qiao, Qingtian Ma, Tong Zhu, Jiawen Bu, Jinqi Xue, Caigang Liu
Abstract
may be an oncogene in the development of breast cancer and thus may as a novel biomarker and therapeutic target for breast cancer.
Topics & Concepts
Breast cancerBiomarkerMedicineOncologyInternal medicineCancer researchCancerBiologyBiochemistryFerroptosis and cancer prognosisMicroRNA in disease regulationRNA modifications and cancer